3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
3
Terminated
2
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
1
Interventions
pembrolizumab
85
Specimen Handling
79
Carboplatin
73
Magnetic Resonance Spectroscopy
71
Biopsy
58
Nivolumab
55
Cisplatin
54
Paclitaxel
46
Cyclophosphamide
44
durvalumab
37
Radiotherapy
36
Radiation
35
olaparib
34
Rituximab
34
Etoposide
33
Dexamethasone
33
Ipilimumab
30
Gemcitabine
30
Lenalidomide
28
Taxes
27
Doxorubicin
27
Docetaxel
27
Pemetrexed
26
Bevacizumab
24
Prednisone
23
Cytarabine
23
X-Rays
22
Trastuzumab
21
cabozantinib
20
Disulfides
20
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Has results
×
vistusertib
×
Clear all
NCT03334617
2025-10-27
HUDSON
AstraZeneca
Phase 2
Active not recruiting
528 enrolled
16 charts